Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients — Vijay Bhoj (UNIVERSITY OF P
Abstract Kidney transplant is the treatment of choice for patients with end-stage renal disease (ESRD), as it extends survival, improves quality of life and is highly cost-effective. However, for abou
| Project title | Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients |
|---|---|
| Project number | 1U01AI163087-01 |
| PI name | Vijay Bhoj |
| Institution | UNIVERSITY OF PENNSYLVANIA |
| Funding mechanism | U01 |
| Agency | NIAID |
| Award amount | $2.98M |
| Fiscal year | 2021 |
| Project start | 2021-08-20T00:00:00 |
| Project end | 2028-05-31T00:00:00 |
| Abstract | Abstract Kidney transplant is the treatment of choice for patients with end-stage renal disease (ESRD), as it extends survival, improves quality of life and is highly cost-effective. However, for abou |
| Key terms | <Address><Alloantibodies><Allografting><Antibodies><Antibody Repertoire><Antibody Response><Antigens |
$799/mo
Try GrantRadar →